01. The evolution of the Banff classification schema for diagnosing renal allograft rejection and its implications for clinicians.
02. Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies.
03. Donor-Derived Cell-Free DNA and Active Rejection in Renal Allografts.
04. The Monitoring of Donor-derived Cell-free DNA in Kidney Transplantation.
05. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.
06. Review: The transcripts associated with organ allograft rejection.
07. Prospective cohort study of Torque Teno Virus (TTV) viral load kinetics and the association with graft rejection in renal transplant patients.
08. Role of Biomarkers in Detecting Acute Rejection in Kidney Transplantation.
09. Diagnosis of renal transplant rejection: Banff classification and beyond.
10. Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation-Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation.
11. Renal Endothelial Cytotoxicity Assay to Diagnose and Monitor Renal Transplant Recipients for Anti- Endothelial Antibodies.
12. Glomerular macrophage index (GMI) in kidney transplant biopsies is associated with graft outcome.
13. Biomarkers of Rejection in Kidney Transplantation, Scott G et.al. ; AJKD 2024.
14. Microvascular Inflammation of Kidney Allografts and Clinical Outcomes, M. Sablik et.al. ; NEJM 2024.
